Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Oncology
Researchers' findings advance oncology research
March 24th, 2005
Investigators in the People's Republic of China, United States and Canada have published new oncology data. Study 1: Antisense blockade of glucose transporter 5 cuts off breast cancer cell growth. "In recent years, successful examples of antisense oligonucleotide (AS) therapy for genetic diseases have stimulated scientists to investigate its application on cancer diseases. AS can be used to down-regulate the mRNA and protein expression by annealing to specific region of the target mRNA which is responsible for the malignancy. Glucose transporter 5 (Glut5) is a tissue specific transporter that can be found on breast cancer tissues but not on normal...
Source: Women's Health Weekly (2005-03-24)
|
